Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rinki Deo

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of the Academy of Nutrition and Dietetics|February 5, 2023
Trends in Quick-Service Restaurants near Public Schools in the United States: Differences by Community, School, and Student CharacteristicsDeborah A Olarte, Joshua Petimar, Peter James, et al.
Annals of Internal Medicine|February 21, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 InfectionRinki Deo, Manish C Choudhary, Carlee Moser, et al.
Medrxiv : the Preprint Server for Health Sciences|August 19, 2022
Viral and Symptom Rebound in Untreated COVID-19 InfectionRinki Deo, Manish C Choudhary, Carlee Moser, et al.
Plos Pathogens|April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
Science Translational Medicine|April 22, 2026
Expansion of stemlike HIV-specific CD8<sup>+</sup> T cells and limited viral epitope diversity characterize durable posttreatment control of HIVCharles R Crain, Aljawharah Alrubayyi, Itai Muzhingi, et al.
Pathogens & Immunity|August 21, 2024
Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody TreatmentUrvi M Parikh, Amy L Heaps, Daniela Moisi, et al.
Pathogens & Immunity|September 9, 2024
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody ResponseMarc-Kendy Paul, Manish C Choudhary, Amy L Heaps, et al.
The Journal of Infectious Diseases|August 31, 2023
Variant-Specific Viral Kinetics in Acute COVID-19Ruy M Ribeiro, Manish C Choudhary, Rinki Deo, et al.
Iscience|March 24, 2025
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodiesRachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of the Academy of Nutrition and Dietetics|February 5, 2023
Trends in Quick-Service Restaurants near Public Schools in the United States: Differences by Community, School, and Student CharacteristicsDeborah A Olarte, Joshua Petimar, Peter James, et al.
Annals of Internal Medicine|February 21, 2023
Symptom and Viral Rebound in Untreated SARS-CoV-2 InfectionRinki Deo, Manish C Choudhary, Carlee Moser, et al.
Medrxiv : the Preprint Server for Health Sciences|August 19, 2022
Viral and Symptom Rebound in Untreated COVID-19 InfectionRinki Deo, Manish C Choudhary, Carlee Moser, et al.
Plos Pathogens|April 18, 2024
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibodyTin Phan, Carolin Zitzmann, Kara W Chew, et al.
Science Translational Medicine|April 22, 2026
Expansion of stemlike HIV-specific CD8<sup>+</sup> T cells and limited viral epitope diversity characterize durable posttreatment control of HIVCharles R Crain, Aljawharah Alrubayyi, Itai Muzhingi, et al.
Pathogens & Immunity|August 21, 2024
Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody TreatmentUrvi M Parikh, Amy L Heaps, Daniela Moisi, et al.
Pathogens & Immunity|September 9, 2024
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody ResponseMarc-Kendy Paul, Manish C Choudhary, Amy L Heaps, et al.
The Journal of Infectious Diseases|August 31, 2023
Variant-Specific Viral Kinetics in Acute COVID-19Ruy M Ribeiro, Manish C Choudhary, Rinki Deo, et al.
Iscience|March 24, 2025
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodiesRachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Pageof 4